Epidermolysis Bullosa Dystrophica
"Epidermolysis Bullosa Dystrophica" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Form of epidermolysis bullosa characterized by atrophy of blistered areas, severe scarring, and nail changes. It is most often present at birth or in early infancy and occurs in both autosomal dominant and recessive forms. All forms of dystrophic epidermolysis bullosa result from mutations in COLLAGEN TYPE VII, a major component fibrils of BASEMENT MEMBRANE and EPIDERMIS.
| Descriptor ID |
D016108
|
| MeSH Number(s) |
C16.131.831.493.160 C16.320.850.275.160 C17.300.200.367 C17.800.804.493.160 C17.800.827.275.160 C17.800.865.410.160
|
| Concept/Terms |
Epidermolysis Bullosa Dystrophica- Epidermolysis Bullosa Dystrophica
- Bullosa Dystrophica, Epidermolysis
- Bullosa Dystrophicas, Epidermolysis
- Dystrophica, Epidermolysis Bullosa
- Dystrophicas, Epidermolysis Bullosa
- Epidermolysis Bullosa Dystrophicas
- Epidermolysis Bullosa, Dystrophic
- Dystrophic Epidermolysis Bullosa
- Bullosa, Dystrophic Epidermolysis
- Bullosas, Dystrophic Epidermolysis
- Dystrophic Epidermolysis Bullosas
- Epidermolysis Bullosas, Dystrophic
Hallopeau-Siemens Disease- Hallopeau-Siemens Disease
- Hallopeau Siemens Disease
- Epidermolysis Bullosa Dystrophica, Autosomal Recessive
- Dystrophic Epidermolysis Bullosa, Autosomal Recessive
- Epidermolysis Bullosa Dystrophica, Recessive
- Epidermolysis Bullosa Dystrophica, Hallopeau-Siemens Type
- Epidermolysis Bullosa Dystrophica, Hallopeau Siemens Type
Cockayne-Touraine Disease- Cockayne-Touraine Disease
- Cockayne Touraine Disease
- Cockayne-Touraine Type Epidermolysis Bullosa
- Cockayne Touraine Type Epidermolysis Bullosa
- Epidermolysis Bullosa Dystrophica, Dominant
- Epidermolysis Bullosa Dystrophica, Cockayne-Touraine Type
- Epidermolysis Bullosa Dystrophica, Cockayne Touraine Type
|
Below are MeSH descriptors whose meaning is more general than "Epidermolysis Bullosa Dystrophica".
Below are MeSH descriptors whose meaning is more specific than "Epidermolysis Bullosa Dystrophica".
This graph shows the total number of publications written about "Epidermolysis Bullosa Dystrophica" by people in this website by year, and whether "Epidermolysis Bullosa Dystrophica" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 1 | 0 | 1 |
| 2018 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Epidermolysis Bullosa Dystrophica" by people in Profiles.
-
Transition of care in patients with epidermolysis bullosa: A survey study. Pediatr Dermatol. 2023 Mar; 40(2):258-260.
-
Gastrostomy tube feeding in epidermolysis bullosa: A multi-center assessment of caregiver satisfaction. Pediatr Dermatol. 2023 Mar; 40(2):270-275.
-
A retrospective analysis of diagnostic testing in a large North American cohort of patients with epidermolysis bullosa. J Am Acad Dermatol. 2022 05; 86(5):1063-1071.
-
APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa. Sci Transl Med. 2018 08 22; 10(455).
-
Sequence variants in nine different genes underlying rare skin disorders in 10 consanguineous families. Int J Dermatol. 2017 Dec; 56(12):1406-1413.
-
Intravenously Administered Recombinant Human Type VII Collagen Derived from Chinese Hamster Ovary Cells Reverses the Disease Phenotype in Recessive Dystrophic Epidermolysis Bullosa Mice. J Invest Dermatol. 2015 Dec; 135(12):3060-3067.
-
Aminoglycosides restore full-length type VII collagen by overcoming premature termination codons: therapeutic implications for dystrophic epidermolysis bullosa. Mol Ther. 2014 Oct; 22(10):1741-52.
-
De novo anti-type VII collagen antibodies in patients with recessive dystrophic epidermolysis bullosa. J Invest Dermatol. 2014 Apr; 134(4):1138-1140.
-
Topical application of recombinant type VII collagen incorporates into the dermal-epidermal junction and promotes wound closure. Mol Ther. 2013 07; 21(7):1335-44.
-
Intravenously injected recombinant human type VII collagen homes to skin wounds and restores skin integrity of dystrophic epidermolysis bullosa. J Invest Dermatol. 2013 Jul; 133(7):1910-3.